Bayer’s oncology business looks to collect $10B in sales by 2030, exec says

Last year, former GSK oncology head Christine Roth took on the challenge of leading the oncology group at German pharma giant Bayer. Her task—to push the company further into the lucrative market—has been bolstered by prostate cancer drug Nubeqa’s second approval and a subsequent sales boost.